Wockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...

Wockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...

HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...

A high-stakes meeting between US President Trump and Chinese President Xi Jinping is closely watched for signs of stability amid escalating...

Elmed Life Sciences has raised $2.7 million from Agrisure Fund, which is managed by Nabard-backed Nabventures. The company develops and man...

A groundbreaking ceremony led by Union Minister Jitendra Singh has marked the start of a new Rs 600 crore pharmaceutical manufacturing plan...

Antibiotics are losing their power as germs grow stronger, a crisis fueled by everyday misuse. Experts urge parents to rethink treating min...

Researchers have used AI to design two promising antibiotics that are helpful in combating drug-resistant bacteria, including gonorrhoea an...

The Centre has also asked state drug regulators to take "strong policy measures including stringent regulatory action on the over-the-count...

Buy Dishman Carbogen Amcis Ltd. at a price target of Rs 355.

"At a time where the business narrative is predominantly dominated by tech, it is so heartening to see the Economics Times giving a platfor...

Despite the complexities, long durations and dearth of money required for such research, several young companies are making a global impact...

Cautious use includes taking antibiotics only for diagnosed bacterial infections.

Teixobactin can treat many common bacterial infections such as tuberculosis, septicemia and C Diff or clostridium difficile colitis.

Described as the most important innovation in the discovery of antibiotics since Alexander Fleming's original breakthrough more than 80 yea...

Helperby will supply Cadila Pharma with Antibiotic Resistance Breakers whilst Cadila will develop the combinations with old antibiotics.

Domestic pharma major Wockhardt has filed a case with the Bombay High Court, after the Indian Patent office rejected its patent application...